130 related articles for article (PubMed ID: 20541561)
1. Novel tumor growth inhibition mechanism by cell cycle regulator cdk2ap1 involves antiangiogenesis modulation.
Zolochevska O; Figueiredo ML
Microvasc Res; 2010 Dec; 80(3):324-31. PubMed ID: 20541561
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function.
Zolochevska O; Figueiredo ML
Prostate; 2009 Oct; 69(14):1586-97. PubMed ID: 19585490
[TBL] [Abstract][Full Text] [Related]
3. Expression of cell cycle regulator cdk2ap1 suppresses tumor cell phenotype by non-cell-autonomous mechanisms.
Zolochevska O; Figueiredo ML
Oral Oncol; 2009 Sep; 45(9):e106-12. PubMed ID: 19515604
[TBL] [Abstract][Full Text] [Related]
4. miR-205 promotes proliferation and invasion of laryngeal squamous cell carcinoma by suppressing CDK2AP1 expression.
Zhong G; Xiong X
Biol Res; 2015 Oct; 48():60. PubMed ID: 26515287
[TBL] [Abstract][Full Text] [Related]
5. Clinical aggressiveness of myxofibrosarcomas associates with down-regulation of p12CDK2AP1: prognostic implication of a putative tumor suppressor that induces cell cycle arrest and apoptosis via mitochondrial pathway.
Li CF; Huang HY; Wu WR; Liang SS; Chen YL; Chen LR; Peng YT; Lee HC; Shiue YL
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S711-20. PubMed ID: 24889487
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of CDK2AP1 in primary human fibroblasts induces p53 dependent senescence.
Alsayegh KN; Gadepalli VS; Iyer S; Rao RR
PLoS One; 2015; 10(3):e0120782. PubMed ID: 25785833
[TBL] [Abstract][Full Text] [Related]
7. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of CDK2AP1 by RNA interference inhibits cell growth and tumorigenesis of human glioma.
Xu Y; Wang J; Fu S; Wang Z
Neurol Res; 2014 Jul; 36(7):659-65. PubMed ID: 24620959
[TBL] [Abstract][Full Text] [Related]
9. miR-21 downregulates the tumor suppressor P12 CDK2AP1 and stimulates cell proliferation and invasion.
Zheng J; Xue H; Wang T; Jiang Y; Liu B; Li J; Liu Y; Wang W; Zhang B; Sun M
J Cell Biochem; 2011 Mar; 112(3):872-80. PubMed ID: 21328460
[TBL] [Abstract][Full Text] [Related]
10. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q
J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957
[TBL] [Abstract][Full Text] [Related]
11. Double edge: CDK2AP1 in cell-cycle regulation and epigenetic regulation.
Wong DT; Kim JJ; Khalid O; Sun HH; Kim Y
J Dent Res; 2012 Mar; 91(3):235-41. PubMed ID: 21865592
[TBL] [Abstract][Full Text] [Related]
12. Cell-cycle regulators cdk2ap1 and bicalutamide suppress malignant biological interactions between prostate cancer and bone cells.
Zolochevska O; Figueiredo ML
Prostate; 2011 Mar; 71(4):353-67. PubMed ID: 20812223
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the CDK2-associated protein-1, p12(DOC-1/CDK2AP1), with its homolog, p14(DOC-1R).
Buajeeb W; Zhang X; Ohyama H; Han D; Surarit R; Kim Y; Wong DT
Biochem Biophys Res Commun; 2004 Mar; 315(4):998-1003. PubMed ID: 14985111
[TBL] [Abstract][Full Text] [Related]
14. The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis.
Li Y; Xiao M; Guo F
Tumour Biol; 2017 May; 39(5):1010428317705508. PubMed ID: 28475012
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclin-dependent kinase 2-associated protein 1 confers an independent prognosticator in nasopharyngeal carcinoma: a cohort study.
Wu LC; Chen YL; Wu WR; Li CF; Huang HY; Lee SW; Chang SL; Lin CY; Chen YH; Hsu HP; Lu PJ; Shiue YL
J Clin Pathol; 2012 Sep; 65(9):795-801. PubMed ID: 22791769
[TBL] [Abstract][Full Text] [Related]
17. Transcription Factor Prospero Homeobox 1 (PROX1) as a Potential Angiogenic Regulator of Follicular Thyroid Cancer Dissemination.
Rudzińska M; Mikula M; Arczewska KD; Gajda E; Sabalińska S; Stępień T; Ostrowski J; Czarnocka B
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717665
[TBL] [Abstract][Full Text] [Related]
18. Propofol suppresses proliferation, invasion and angiogenesis by down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal squamous cell carcinoma cells.
Xu YB; Du QH; Zhang MY; Yun P; He CY
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2486-94. PubMed ID: 24089228
[TBL] [Abstract][Full Text] [Related]
19. DeltaNp63alpha-dependent expression of Id-3 distinctively suppresses the invasiveness of human squamous cell carcinoma.
Higashikawa K; Yoneda S; Tobiume K; Saitoh M; Taki M; Mitani Y; Shigeishi H; Ono S; Kamata N
Int J Cancer; 2009 Jun; 124(12):2837-44. PubMed ID: 19267405
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas.
Detmar M; Velasco P; Richard L; Claffey KP; Streit M; Riccardi L; Skobe M; Brown LF
Am J Pathol; 2000 Jan; 156(1):159-67. PubMed ID: 10623663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
